Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-08-006525
Filing Date
2008-05-14
Accepted
2008-05-14 06:02:48
Documents
4
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2185173z10-q.htm 10-Q 307842
2 EXHIBIT 31.1 a2185173zex-31_1.htm EX-31.1 7213
3 EXHIBIT 31.2 a2185173zex-31_2.htm EX-31.2 7260
4 EXHIBIT 32.1 a2185173zex-32_1.htm EX-32.1 4248
  Complete submission text file 0001047469-08-006525.txt   327792
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 08829422
SIC: 2834 Pharmaceutical Preparations